Medications for OUD are defined as using pharmacy and medical claims for US Food and Drug Administration–approved medications for OUD including buprenorphine, methadone, and naltrexone. The denominator includes full-benefit Medicaid enrollees aged 12 through 64 years diagnosed with OUD in the calendar ...
Many probationers with OUDs cannot access FDA-approved medications to treat their disorders despite the strong evidence of their effectiveness. The barriers to medications for those under probation supervision include practitioners’ negative attitudes toward medications, costs, stigma, and diversion risk. ...
Results are consistent with other studies of the provision of MAT during incarceration,4 yet it is remarkable that the reduction in mortality occurred in the face of a devastating, illicit, fentanyl-driven overdose epidemic.5,6 Alternative explanations for the observed reductions (eg, differences in...
This study is a retrospective analysis evaluating the role of antihypertensive and antidiabetic agents on the renal hemodynamic effects of SGLT2 inhibitors in type 2 DM. The study was approved by the Ethics Committee of Tokyo Bay Urayasu-Ichikawa Medical Center with waiver of the requirement for o...
Since the introduction of the first chemotherapeutic regimens for the treatment of oncological disease, hundreds of drugs have been approved for cancer tre... M Carlesimo,F Pigliacelli,A D'Arino,... - 《Journal of Cosmetic Dermatology》 被引量: 0发表: 2020年 Recommendations on the treatment ...
To review current cardiovascular medications for benefits and potential harms during COVID-19. Several cardiovascular drugs have a potential to protect pat
has the potential to cause serious adverse reactions, and to formulate a plan for close monitoring during therapy. The FDA BBW provides the extra layer of safety but many healthcare providers fail to comply with these warnings. Currently, there are 26 FDA-approved antiseizure medications in the...